Advertisement

How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated?

Eli Lilly researchers prepare cells to produce possible COVID-19 antibodies in a laboratory in Indianapolis. The drugmaker has asked the U.S. government to allow emergency use of its experimental antibody therapy. (AP)
Eli Lilly researchers prepare cells to produce possible COVID-19 antibodies in a laboratory in Indianapolis. The drugmaker has asked the U.S. government to allow emergency use of its experimental antibody therapy. (AP)

Related:

Advertisement

More from WBUR

Listen Live
Close